Lapatinib usage, dosage and adverse reactions

Lapatinib, as a targeted therapy forHER2-positive breast cancer, has brought new treatment hope to many patients. However, using this medicine correctly and understanding its possible side effects are critical to ensuring treatment effectiveness and patient safety.

In the treatment of HER2-positive metastatic breast cancer, the recommended dose of lapatinib is 1,250 mg, taken orally once daily on days 1 to 21 of each 21-day cycle. At the same time, it is often used in combination with capecitabine to enhance the therapeutic effect. The recommended dose of capecitabine is 2,000 mg/m²/day taken orally in two doses, approximately 12 hours apart, on days 1 to 14. It is worth noting that lapatinib should be taken at least one hour before or one hour after a meal, and the daily dose should be taken in one go (i.e., 5 tablets taken at one time). It is not recommended to take it in divided doses.

For patients with hormone receptor-positive, HER2-positive metastatic breast cancer, the recommended dose of lapatinib is slightly different, 1,500 mg orally once daily, in combination with letrozole. At this time, the recommended dose of letrozole is 2.5 mg once daily. Similarly, lapatinib should be taken at least one hour before or one hour after a meal, and the daily dose should be 6 tablets taken at one time.

However, the use of lapatinib is not without risks. During use, patients need to pay close attention to body reactions to prevent adverse reactions. Severe allergic reactions, such as hives, trouble breathing, swelling of the face or throat, and severe skin problems, such as fever, sore throat, burning eyes, sore skin, and a red or purple rash with blistering and flaking, are indications for emergency medical attention.

In addition, lapatinib can cause serious or fatal liver problems. Patients should contact their doctor immediately if they experience upper abdominal pain, itching, dark urine, chalky stools, or jaundice (yellowing of the skin and eyes). At the same time, symptoms such as rapid heartbeat, chest trembling, shortness of breath, sudden severe dizziness, etc. also need to be taken seriously and the doctor should be notified in time.

In addition to the serious side effects mentioned above, common side effects of lapatinib include indigestion, loss of appetite, nausea, vomiting, diarrhea, rash, itching, dry skin, acne, pain or redness on the palms or soles of the feet, nail problems, weakness and fatigue, nose bleeding, mouth ulcers, thinning hair, and headaches. Although these side effects are not life-threatening, they will have a certain impact on the patient's quality of daily life.

Therefore, when using lapatinib to treat breast cancer, patients must strictly follow the doctor's instructions, pay close attention to the body's reaction, and promptly communicate with the doctor any discomfort or abnormalities. Doctors should also formulate a reasonable medication plan based on the patient's specific situation to minimize the occurrence of side effects and ensure the patient's therapeutic effect and safety.

xa0

Reference materials:https://www.rxlist.com/tykerb-drug.htm#side_effects